An interventional study of Theta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation) in Autism Spectrum Disorder and Theta Burst Stimulation, sponsored by Chang Gung Memorial Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-11.
Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital — 5 open to participants now, 7 under way, none of them phase 3. Autism Spectrum Disorder · Chang Gung Memorial Hospital.
Among the 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 11 with no phase, and was the 14th registered.
1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.
Browse Autism Spectrum Disorder studies →5 of the 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 8–30
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 8–30
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 7–30 · Healthy volunteers
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 8–30
By country, each count listing its studies:
Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 60 is above the median of 52 across 1,374 interventional studies indexed under Autism Spectrum Disorder.
Median enrollment 60 across the 12 interventional studies, 180 across the 3 observational. Of the 2 that completed or were terminated, 2 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.
2 of the studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06974838Chang Gung Memorial HospitalExplore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability | 2027-07-31 |
| NCT06290258Chang Gung Memorial HospitalFecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. | 2027-07-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to establish a personalized theta burst stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation, rTMS) protocol considering autistic idiosyncrasy (interindividual variability).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion criteria for typically developing control:
Exclusion criteria for all participants:
Withdrawal criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Eligible participants are adults diagnosed with autism who meet the inclusion criteria of the study.
Device: Theta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation)
Eligible participants are typically developing adults who meet the study's inclusion criteria.
Device: Theta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation)
Participants will receive a single session of either iTBS or cTBS (600 pulses) targeting the right cerebellar Crus I/II. One week after the initial TBS, they will receive another single session of iTBS or cTBS (600 pulses) at the same site.
Functional MRI (default mode network) - BOLD Signal
Blood-oxygen-level-dependent (BOLD) signal is a measurement used in fMRI, which reflects the neural activity.
Time frame: Baseline, Week 1, Week 2
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Baseline
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 1 (5 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 2 (5 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 1 (10 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 2 (10 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 1 (15 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 2 (15 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 1 (20 minutes post-TBS)
MEP amplitude
MEP (motor evoked potential) amplitude is a measure of corticospinal excitability.
Time frame: Week 2 (20 minutes post-TBS)
Started Jul 2025 (actual). Primary completion is estimated for Jun 2028, 35 months after the start.
Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 35 months is above that.
Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital →